AnalystBook Research · Company Intelligence

Evolent Health, Inc.

EVHNYSE

Built from Evolent Health, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data

Revenue decreased 26.6% to $1.88B, while Net income decreased 767.4% to ($534.5M).

The read at a glance✓ Audited against SEC data
  • Scale — FY2025 revenue $1.88BWatch
  • Profitability — Net income ($534.5M)Watch
  • Cash generation — Free cash flow $4.8MOK
  • Accounting — Formula distress score · no manipulation flag · earnings quality safeWatch
  • Insiders — 1 buys; 0 sells in 365 daysOK
  • Capital — share repurchases were $40.0MNote

Business

Evolent Health, Inc.: Our acquisitions have been focused on companies with extensive experience assisting customers in managing the large and complex specialties of oncology, cardiology, radiology, musculoskeletal, physical medicine, and genetics care.

Where the revenue comes from

Fiscal 2025, as Evolent Health, Inc. reports it. History and quarterly detail are in the app.

  • Performance Suite$1.1B
  • Specialty Technology and Services Suite$353.2M
  • Administrative Services$226.7M
  • Cases$169.0M

Leadership changes

From Evolent Health, Inc.'s own filings, the day they're filed.

  • Jill Smith · chief executive officer · appointmenteff. 2025-12-02
  • Diane Holder · Directors · departureeff. 2025-04-16
  • Russell Glass · director · appointmenteff. 2024-02-14

Latest filings

  • 8-K · Company announcement2026-08-06
  • 10-Q · Quarterly report2026-08-06
  • 8-K · Company announcement2026-06-04
  • 8-K · Company announcement2026-05-07
  • 10-Q · Quarterly report2026-05-07
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Evolent Health, Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

See the full EVH record — start free

14-day free trial, no credit card. For research purposes only; not investment advice.